PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryJan 12, 2015	Integra LifeSciences Acquires Metasurg's Foot and Ankle Product Portfolio PLAINSBORO, N.J., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that, in December, it closed on the acquisition of the product portfolio from Metasurg. The addition of the Metasurg product portfolio enhances Integra's lower extremity	View HTML Integra LifeSciences Acquires Metasurg's Foot and Ankle Product Portfolio 12.2 KB
Toggle SummaryJan 5, 2015	Integra LifeSciences to Participate in the 33rd Annual J.P. Morgan Healthcare Conference in January PLAINSBORO, N.J., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the 33 rd Annual J.P. Morgan Healthcare Conference. At 4:30PM PT on Wednesday, January 14, 2015, Mr. Peter Arduini, Integra's President and Chief	View HTML Integra LifeSciences to Participate in the 33rd Annual J.P. Morgan Healthcare Conference in January 13.4 KB
Toggle SummaryDec 17, 2014	Integra LifeSciences Launches Integra(R) Meshed Dermal Regeneration Template Expands Skin and Wound Product Line	View HTML Integra LifeSciences Launches Integra(R) Meshed Dermal Regeneration Template 12.7 KB
Toggle SummaryNov 20, 2014	Integra LifeSciences to Participate in the Piper Jaffray and Oppenheimer Healthcare Conferences in December PLAINSBORO, N.J., Nov. 20, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences in December: At 9:30AM ET on Tuesday, December 2, 2014, Mr. Glenn Coleman, Integra's Chief Financial Officer, will present at	View HTML Integra LifeSciences to Participate in the Piper Jaffray and Oppenheimer Healthcare Conferences in December 10.6 KB
Toggle SummaryNov 13, 2014	Integra LifeSciences Announces FDA Clearance and Controlled Market Release of Expandable Interbody System for Spinal Surgery PLAINSBORO, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the controlled market release of the Integra ® Expandable Interbody System, in the United States. The system, which received 510(k) clearance from the United States Food and	View HTML Integra LifeSciences Announces FDA Clearance and Controlled Market Release of Expandable Interbody System for Spinal Surgery 11.6 KB
Toggle SummaryNov 12, 2014	Integra LifeSciences Introduces Integra(R) Pocket Strip and Integra(R) Shaped Strip DBM Implants Company's First DBM Implants Specifically Designed for Posterior Lumbar Spine Fusion Procedures	View HTML Integra LifeSciences Introduces Integra(R) Pocket Strip and Integra(R) Shaped Strip DBM Implants 12 KB
Toggle SummaryNov 3, 2014	Integra LifeSciences Announces Strategic Portfolio Alignment and Plans to Create Stand-Alone Spine Business as a Separate Public Company Plans to Spin Off Spine Business to Create SeaSpine, a New Publicly Traded Company, By Means of Tax-Free Distribution to Integra Shareholders Both Companies Will be Leaders in Providing Regenerative Technologies Integra to Operate as Two Global Divisions in 2015 Upon Completion of the Spin-Off:	View HTML Integra LifeSciences Announces Strategic Portfolio Alignment and Plans to Create Stand-Alone Spine Business as a Separate Public Company 23.5 KB
Toggle SummaryNov 3, 2014	Integra LifeSciences Reports Third Quarter 2014 Financial Results Revenue Increased 7.7% to $229.7 Million GAAP EPS was $0.30 Adjusted EPS Increased 16% to $0.76 Operating Cash Flow was $31.1 Million PLAINSBORO, N.J., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the third quarter	View HTML Integra LifeSciences Reports Third Quarter 2014 Financial Results 23.5 KB
Toggle SummaryOct 27, 2014	Integra LifeSciences Completes the Acquisition of MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines From Medtronic PLAINSBORO, N.J., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has completed the acquisition of the MicroFrance and Xomed manual ear, nose and throat (ENT) and laparoscopy instrumentation lines from Medtronic.	View HTML Integra LifeSciences Completes the Acquisition of MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines From Medtronic 10.6 KB
Toggle SummaryOct 9, 2014	Integra LifeSciences to Host Its Third Quarter 2014 Earnings Results Conference Call on November 3, 2014 PLAINSBORO, N.J., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its third quarter 2014 financial results on Monday, November 3, 2014. The company has scheduled a conference call for 4:30 PM ET the same day to discuss the results.	View HTML Integra LifeSciences to Host Its Third Quarter 2014 Earnings Results Conference Call on November 3, 2014 10 KB